Some applications of CRISPR are raising ethical and other concerns, and are presenting interesting policy challenges to our current oversight system for research in the life sciences. What can we learn from previous experiences with emerging biotechnologies and how can we adapt our current policy framework to the gene editing technologies of today and tomorrow?
This lecture has been canceled due to the speaker’s illness.
We have reached our seating capacity for this event. You can still watch the lecture live on your desktop or mobile device on the Library’s Facebook page or at the following link: